BRCA1 and breast cancer: Data for the Chinese population showed that the pathogenic or likely pathogenic mutations of BRCA1/2 were identified in 5.3% unselected Chinese breast cancer patients and in 18.1% familial breast cancer patients (Sun et al., 2017).